This article is more than 5 years old. Information may no longer be current.
AIBD 2017 to highlight novel therapies, coordinated care, new surgical track
Click Here to Manage Email Alerts
ORLANDO — Healio Gastroenterology and Liver Disease is the official media partner of the Advances in Inflammatory Bowel Disease annual meeting and will provide live coverage from November 9 to November 11.
Thousands of attendees will gather at the Walt Disney World Dolphin Hotel for a program endorsed by the American College of Gastroenterology and the American Society of Colon and Rectal Surgeons, and focused on the coordinated, multidisciplinary care of patients with IBD. Over 3 days, experts will lead dozens of presentations across four educational tracks, and share hundreds of clinical, translational and research abstracts.
“The focus of AIBD is to help clinicians integrate the care of IBD patients with advanced practitioners, nurses, dieticians, behavioral therapists, surgeons and pharmacists,” AIBD co-chair Stephen B. Hanauer, MD, of the Feinberg School of Medicine at Northwestern University in Chicago, told Healio Gastroenterology and Liver Disease. “The coordination of care for IBD patients has become increasingly complex with the expanding medical armamentarium that requires not only disease-specific approaches, but also general health maintenance that is increasingly required within IBD practices.”
According to Hanauer, impactful topics at this year’s meeting will include therapeutic monitoring, optimization of individual and combination therapies, and monitoring health maintenance in the IBD patient population.
“The expanding concepts of medical homes for IBD patients as well as presentations on evolving and novel therapies will be incorporated into therapeutic paradigms,” he said. “Expanding programs in pediatrics and surgery will continue to focus on optimizing medical and surgical therapies and transitioning patients amongst and between specialties.”
The surgical track is a new addition to the program this year, and will highlight “new surgical techniques and what every gastroenterologist should know about surgery in IBD,” AIBD co-chair Miguel Regueiro, MD, of the University of Pittsburgh School of Medicine, told Healio Gastroenterology and Liver Disease. "There will be parallel sessions for our nurses, advanced practice nurses, and CRNP/PAs who are central in the total care of our IBD patients.”
Regueiro added that the importance of multidisciplinary teams and patient-centered care is a central focus of this year’s program.
“Starting with the first session, we will focus on new models of health care, the vital role of medical-surgical care for patients with Crohn’s and colitis, and the approach to the ‘whole’ patient through psychosocial care and management of pain,” he said. Additionally, the meeting “will provide health care professionals with up-to-date information on novel therapeutics and positioning of medications.”
Healio Gastroenterology and Liver Disease staff will report live on breaking news presented at the meeting and capture video interviews with experts to gain their perspectives on important presentations. Visit and follow @HealioGastro on Twitter for the latest news emerging from #AIBD2017. – by Adam Leitenberger
Disclosures: Hanauer and Regueiro are co-chairs of AIBD 2017.